Abciximab, a glycoprotein IIb/IIIa receptor antagonist manufactured by Janssen Biologics BV and distributed by Eli Lilly under the trade name ReoPro,...
9 KB (671 words) - 19:42, 20 December 2023
a class of antiplatelet agents. Several GpIIb/IIIa inhibitors exist: abciximab (abcixifiban) (ReoPro) eptifibatide (Integrilin) tirofiban (Aggrastat)...
2 KB (175 words) - 18:45, 17 January 2024
fibrinogen. The gpIIb/IIIa receptor is a target of several drugs including abciximab, eptifibatide, and tirofiban. Once platelets are activated, granules secrete...
5 KB (500 words) - 06:24, 21 December 2023
(Persantine) Glycoprotein IIB/IIIA inhibitors (intravenous use only) Abciximab (ReoPro) Eptifibatide (Integrilin) Tirofiban (Aggrastat) Irreversible...
18 KB (1,752 words) - 10:58, 11 August 2024
GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market. Eptifibatide...
11 KB (947 words) - 16:29, 11 May 2024
Churchill Livingstone. pp. 241, for the examples infliximab, basiliximab, abciximab, daclizumab, palivusamab, gemtuzumab, alemtuzumab and rituximab, and mechanism...
49 KB (4,964 words) - 09:59, 20 September 2024
Developed the drug that is recommended for all cardiac angioplasties (abciximab) 1974 Created the first MRI image of a living organism Discovered the...
151 KB (13,767 words) - 11:45, 24 September 2024
(INN) abatacept (USAN) Abasol (York Pharma) Abbokinase ABC Pack ABCD abciximab (INN) abecarnil (INN) Abecma abediterol (INN) Abegrin Abelcet (Sigma-Tau)...
2 KB (210 words) - 19:12, 20 August 2024
points to the widely accepted pronunciation of any given INN. For example, abciximab is predictably /æbˈsɪksɪmæb/, because for INNs ending in -ciximab, the...
26 KB (2,150 words) - 12:06, 11 September 2024
Sakmar was acting-president from 2002.) Barry Coller, who invented the Abciximab, currently serves as the Vice President for Medical Affairs. In all, as...
37 KB (3,212 words) - 18:23, 27 June 2024